Myocardial tissue characterization by magnetic resonance imaging: Novel applications of T1 and T2 mapping

Journal of Thoracic Imaging

Volumn 29, Issue 3, 2014, Pages 147-154

  Ferreira, Vanessa M ^a   Piechnik, Stefan K ^a   Robson, Matthew D ^a   Neubauer, Stefan ^a   Karamitsos, Theodoros D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

diffuse fibrosis; edema; inflammation; parametric mapping; scarring

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; CARDITIS; CONFERENCE PAPER; HEART; HEART EDEMA; HUMAN; ISCHEMIC HEART DISEASE; NONISCHEMIC CARDIOMYOPATHY; T1 MAPPING; T2 MAPPING; TISSUE CHARACTERIZATION; CARDIAC MUSCLE; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY BLOOD FLOW; DIFFERENTIAL DIAGNOSIS; HEART CONTRACTION; HEART DISEASES; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS;

CONTRAST MEDIUM;

CONTRAST MEDIA; CORONARY CIRCULATION; DIAGNOSIS, DIFFERENTIAL; HEART DISEASES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIAL CONTRACTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84899640704     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0000000000000077     Document Type: Conference Paper

References (77)

1. Karamitsos TD, Francis JM, Myerson S, et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:1407-1424.
2. Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010;121:692-705.
3. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of mri delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100: 1992-2002.
4. Karamitsos TD, Dall'Armellina E, Choudhury RP, et al. Ischemic heart disease: comprehensive evaluation by cardiovascular magnetic resonance. Am Heart J. 2011;162:16-30.
5. Eitel I, Friedrich MG. T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson. 2011;13:13.
6. Salerno M, Kramer CM. Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging. 2013;6:806-822.
7. Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR working group of the european society of cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.
8. Ferreira VM, Piechnik SK, Firoozan S, et al. Acute chest pain and massive LV hypertrophy in a 38-year-old man. Heart. 2013. [Epub ahead of print].
9. Ferreira V, Piechnik S, Dall'Armellina E, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy:a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:42.
10. Sado DM, White SK, Piechnik SK, et al. Identification and assessment of anderson-fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circulation Cardiovasc Imaging. 2013;6:392-398.
11. Messroghli DR, Plein S, Higgins DM, et al. Human myocardium: single-breath-hold mr T1 mapping with high spatial resolution-reproducibility study. Radiology. 2006;238: 1004-1012.
12. Bottomley PA, Foster TH, Argersinger RE, et al. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys. 1984;11:425-448.
13. Messroghli DR, Radjenovic A, Kozerke S, et al. Modified look-locker inversion recovery (MOLLI) for high-resolution T 1 mapping of the heart. Magn Reson Med. 2004;52:141-146.
14. Chow K, Flewitt JA, Green JD, et al. Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med. 2013. [Epub ahead of print].
15. Higgins DM, Ridgway JP, Radjenovic A, et al. T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys. 2005;32:1738-1746.
16. Lee JJ, Liu S, Nacif MS, et al. Myocardial T1 and extracellular volume fraction mapping at 3 Tesla. J Cardiovasc Magn Reson. 2011;13:75.
17. Schelbert E, Testa S, Meier C, et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson. 2011;13:16.
18. Xue H, Shah S, Greiser A, et al. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012;67:1644-1655.
19. Piechnik S, Ferreira V, Lewandowski A, et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5T using ShMOLLI. J Cardiovasc Magn Reson. 2013;15:13.
20. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010; 12:69.
21. Liu CY, Liu YC, Wu C, et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2013;62:1280-1287.
22. Messroghli DR, Walters K, Plein S, et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med. 2007;58: 34-40.
23. Chow K, Flewitt JA, Pagano J, et al. T2-dependent errors in MOLLI T1 values: simulations, phantoms, and in-vivo studies. J Cardiovasc Magn Reson. 2012;14(suppl 1):P281.
24. Robson MD, Piechnik SK, Tunnicliffe EM, et al. T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med. 2013. [Epub ahead of print].
25. White SK, Sado DM, Flett AS, et al. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart. 2012;98:773-779.
26. Ellims A, Iles L, Ling L-h, et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012;14:76.
27. Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574-1580.
28. Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10.
29. Sparrow P, Messroghli DR, Reid S, et al. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Am J Roentgenol. 2006;187:W630-W635.
30. Kawel N, Nacif M, Zavodni A, et al. T1 mapping of the myocardium: Intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson. 2012; 14:26.
31. Miller CA, Naish JH, Bishop P, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373-383.
32. White SK, Sado DM, Fontana M, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955-962.
33. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138-144.
34. Fontana M, White S, Banypersad S, et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multi-breath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson. 2012; 14: 88.
35. Coelho-Filho OR, Mongeon FP, Mitchell R, et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging. 2013;6:134-141.
36. Messroghli D, Greiser A, Frohlich M, et al. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging. 2007;26:1081-1086.
37. Ferreira V, Piechnik S, Dall'Armellina E, et al. T1-mapping for the diagnosis of acute myocarditis using cardiovascular magnetic resonance-comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013;6:1048-1058.
38. Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging. 2012;5:726-733.
39. Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475-484.
40. Karamitsos TD, Piechnik SK, Banypersad SM, et al. Non-contrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6:488-497.
41. Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128:814-822.
42. Been M, Thomson BJ, Smith MA, et al. Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging. Eur Heart J. 1988;9:1250-1256.
43. Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6:295-301.
44. Bull S, White SK, Piechnik SK, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99:932-937.
45. Scholz TD, Martins JB, Skorton DJ. NMR relaxation times in acute myocardial infarction: relative influence of changes in tissue water and fat content. Magn Reson Med. 1992;23:89-95.
46. Higgins CB, Herfkens R, Lipton MJ. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol. 1983; 52:184-188.
47. Williams ES, Kaplan JI, Thatcher F. Prolongation of proton spin lattice relaxation times in regionally ischemic tissue from dog hearts. J Nucl Med. 1980;21:449-453.
48. Dall'Armellina E, Piechnik SK, Ferreira VM, et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson. 2012;14:15.
49. Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5:596-603.
50. Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475-484.
51. Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128:814-822.
52. Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6:295-301.
53. Ferreira VM, Holloway CJ, Piechnik SK, et al. Is it really fat? Ask a T1-map. Eur Heart J Cardiovasc Imaging. 2013. [Epub ahead of print].
54. Sado DM, White SK, Piechnik SK, et al. Native T1 lowering in iron overload and anderson fabry disease; a novel and early marker of disease. J Cardiovasc Magn Reson. 2013;15(suppl 1): O71.
55. Won S, Davies-Venn C, Liu S, et al. Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis. Curr Opin Cardiol. 2013;28:282-289.
56. Sado DM, Flett AS, Banypersad SM, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012;98:1436-1441.
57. Kellman P, Wilson J, Xue H, et al. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson. 2012;14:64.
58. Shah RV, Abbasi SA, Neilan TG, et al. Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc. 2013;2: e000279.
59. Tham E, Haykowsky M, Chow K, et al. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling. J Cardiovasc Magn Reson. 2013;15:48.
60. Wong TC, Piehler KM, Kang IA, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2013. [Epub ahead of print].
61. Plymen CM, Sado DM, Taylor AM, et al. Diffuse myocardial fibrosis in the systemic right ventricle of patients late after mustard or senning surgery: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2013;14:963-968.
62. Banypersad SM, Sado DM, Flett AS, et al. Quantification of myocardial extracellular volume fraction in systemic al amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. 2012;6:34-39.
63. Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012;33:1268-1278.
64. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, et al. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging. 2012;5: 897-907.
65. Broberg CS, Chugh SS, Conklin C, et al. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010;3:727-734.
66. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (dense) functional validations. Circulation. 2006;113:1865-1870.
67. Abdel-Aty H, Cocker M, Meek C, et al. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol. 2009;53: 1194-1201.
68. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475-1487.
69. Yilmaz A, Ferreira V, Klingel K, et al. Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev. 2013;18:747-760.
70. Giri S, Chung YC, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009;11:56.
71. Tunnicliffe EM, Robson MD. Optimising acquisition parameters for myocardial T2 mapping using T2-prep at 3T. J Cardiovasc Magn Reson. 2013;15(suppl 1):W10.
72. Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging. 2011;5:102-110.
73. von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer M, et al. Myocardial T1 and T2 mapping at 3T: reference values, influencing factors and implications. J Cardiovasc Magn Reson. 2013;15:53.
74. Usman AA, Taimen K, Wasielewski M, et al. Cardiac magnetic resonance T2 mapping in the monitoring and follow-up of acute cardiac transplant rejection: a pilot study. Circ Cardiovasc Imaging. 2012;5:782-790.
75. Wassmuth R, Prothmann M, Utz W, et al. Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema. J Cardiovasc Magn Reson. 2013;15:27.
76. van Heeswijk RB, Hln Feliciano, Cd Bongard, et al. Free-breathing 3 T magnetic resonance T2-mapping of the heart. JACC Cardiovasc Imaging. 2012;5:1231-1239.
77. Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011;4:269-278.